HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use NITROGLYCERIN safely and effectively. See full prescribing information for NITROGLYCERIN
NITROGLYCERIN (nitroglycerin) sublingual tablet
Initial U.S. Approval: 1981
INDICATIONS AND USAGE
Nitroglycerin is a nitrate vasodilator indicated for relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. (1)
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
Sublingual tablets, 0.3 mg; 0.4 mg; 0.6 mg. (3)
WARNINGS AND PRECAUTIONS
Most common adverse reactions occurring at a frequency greater than 2% are headache, dizziness and paresthesia. (6)
To report SUSPECTED ADVERSE REACTIONS, contact Greenstone LLC Professional information Services at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Ergotamine: Increased bioavailability of ergotamine. Avoid concomitant use. (7.2)
See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.